Insights

Partnership Potential Aditum Bio has a track record of forming strategic partnerships with other biotech companies like Inmagene Bio and TrialSpark, presenting sales opportunities for collaborative ventures and service provisions.

Funding Success Having successfully raised $70 million in Series A financing, Aditum Bio demonstrates financial stability and potential investment opportunities for organizations looking to support innovative biotech ventures.

Key Personnel Engagement The appointment of key executives like Stephen Kanes as the Chief Executive Officer shows strong leadership commitment within Aditum Bio, opening doors for B2B services catering to C-suite professionals.

Therapeutic Development With a focus on developing therapies for metabolic diseases, renal diseases, autoimmune, and inflammatory disorders, Aditum Bio presents avenues for selling specialized products or services tailored to these medical areas.

Market Expansion Aditum Bio's agile business model and rapid formation approach for clinic-ready therapies position the company for potential geographic and market expansion, offering sales prospects in new territories or segments.

Aditum Bio Tech Stack

Aditum Bio uses 8 technology products and services including WordPress, Microsoft Outlook, Google Cloud, and more. Explore Aditum Bio's tech stack below.

WordPress

Content Management System

Microsoft Outlook

Google Cloud

Infrastructure As A Service

Polyfill

Javascript Libraries

DocuSign

Miscellaneous

PHP

Programming Languages

Greenhouse

Recruitment Marketing

Bootstrap

UI Frameworks

Aditum Bio Email Formats	Example	Percentage
First.Last@aditumbio.com	John.Doe@aditumbio.com	49%
FLast@aditumbio.com	JDoe@aditumbio.com	1%
First.Last@aditumbio.com	John.Doe@aditumbio.com	49%
FLast@aditumbio.com	JDoe@aditumbio.com	1%

Aditum Bio Email Formats

Example

Percentage

First.Last@aditumbio.com

John.Doe@aditumbio.com

49%

FLast@aditumbio.com

JDoe@aditumbio.com

First.Last@aditumbio.com

John.Doe@aditumbio.com

49%

FLast@aditumbio.com

JDoe@aditumbio.com

Frequently Asked Questions

Where is Aditum Bio's headquarters located?

Aditum Bio's main headquarters is located at 1111 Broadway Suite 1300 Oakland, California 94607 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Aditum Bio's official website and social media links?

Aditum Bio's official website is aditumbio.com and has social profiles on LinkedIn.

How much revenue does Aditum Bio generate?

As of October 2024, Aditum Bio's annual revenue reached $1.8M.

What is Aditum Bio's SIC code NAICS code?

Aditum Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aditum Bio have currently?

As of October 2024, Aditum Bio has approximately 40 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Clinical Operations Officer: C. T.Vice President Clinical Operations: C. R.Vice President Quality Assurance: S. A.. Explore Aditum Bio's employee directory with LeadIQ.

What industry does Aditum Bio belong to?

Aditum Bio operates in the Biotechnology Research industry.

What technology does Aditum Bio use?

Aditum Bio's tech stack includes WordPressMicrosoft OutlookGoogle CloudPolyfillDocuSignPHPGreenhouseBootstrap.

What is Aditum Bio's email format?

Aditum Bio's email format typically follows the pattern of . Find more Aditum Bio email formats with LeadIQ.

When was Aditum Bio founded?

Aditum Bio was founded in 2019.

Aditum Bio

Biotechnology ResearchCalifornia, United States11-50 Employees

Aditum is the Latin word for "access," and our mission is to give patients access to medicines that may not otherwise be developed. 

Aditum Bio is a new model of biotech venture capital uniquely positioned to rapidly translate scientific discoveries into innovative new medicines. Aditum Bio brings together unmatched scientific and domain expertise, combined with operational capabilities. Our agile operating model enables rapid company formation, planning and execution for a new model of drug development . We target clinic-ready therapies to help underserved patient populations, rapidly forming companies and staffing them with medical and scientific experts.  

Launched in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research, Dr. Mark Fishman, Aditum Bio currently manages a broad portfolio of clinical stage companies. 

For more information, please visit www.aditumbio.com.

Insights

Similar companies to Aditum Bio

Pivot Bio

DayTwo

AgBiome

Caribou Biosciences

Joyn Bio

Seed Health

Viome

Indigo Agriculture

Aditum Bio Tech Stack

Media & News

Inmagene Bio partners with Aditumbio.

Aditumbio received financing of $70M in Series A on Jul 14th '21.

Aditumbio hires Stephen Kanes as Chief Executive Officer.

Aditumbio is developing therapy for the treatment of metabolic disease and obesity on Aug 31st '21.

Aditumbio partnered with TrialSpark, Inc. on Dec 16th '20.

Aditumbio is developing renal disease therapies.

Aditumbio hires Ilan Zipkin as Vice President of Business Development and Licensing.

Aditum Bio's Email Address Formats